Skip to content

Advancing Ultrasound Imaging of the Heart using Computer Models in Adults

Clinical translation of biophysical modelling for intelligent echocardiography: a prospective observational study investigating the application of deep learning to three-dimensional echocardiogram analysis in adults

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12626001147370
Enrollment
160
Registered
2026-09-15
Start date
2025-04-09
Completion date
Unknown
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to evaluate new artificial intelligence (AI) methods for analysing three-dimensional heart ultrasound images (echocardiograms). The study will include adults who are having a routine echocardiogram as part of their usual clinical care. Researchers will compare the AI-generated measurements with standard echocardiographic measurements to determine whether the new approach is accurate, reliable and able to provide additional information about heart function. Participants' echocardiography and routine clinical data will also be followed over time to investigate whether these measurements can help predict future cardiovascular events. The findings may improve the efficiency, accuracy and accessibility of echocardiography.

Interventions

Patients undergoing clinically indicated transthoracic echocardiography will be studied prospectively. The data collected for the study will consist of copies of the all echocardiographic images and measurements acquired routine clinical care. These may include two-dimensional (2D), three-dimensional (3D), and Doppler (pulsed-wave, continuous-wave and colour Doppler) imaging acquired from standard parasternal, apical, subcostal, and suprasternal views. Routine echocardiographic measurements will

Patients undergoing clinically indicated transthoracic echocardiography will be studied prospectively. The data collected for the study will consist of copies of the all echocardiographic images and measurements acquired routine clinical care. These may include two-dimensional (2D), three-dimensional (3D), and Doppler (pulsed-wave, continuous-wave and colour Doppler) imaging acquired from standard parasternal, apical, subcostal, and suprasternal views. Routine echocardiographic measurements will be made according to standard clinical echocardiography recommendations. The echocardiographic image acquisition is the same as that undertaken as part of routine clinical care; no additional images or measurements are acquired from the participant solely for research purposes. No study-mandated examinations are required. Any further echocardiographic examinations undertaken during follow-up will occur only as part of routine clinical care. Therefore, the number and timing of echocardiograms will vary between participants according to their clinical needs. For participants who provide informed consent, copies of echocardiographic data will be collected from the six months before consent and for two years after consent. Clinical information relevant to cardiovascular health, including medications, electrocardiograms, blood test results, and other cardiac imaging where available, will also be collected from routinely generated health databases. These data will be collected over the same study period. There are no fixed study-specific clinical data collection visits or intervals; the frequency of available clinical information will depend on the participant's routine clinical care. Echocardiographic data will be analysed for research purposes only using artificial intelligence and three-dimensional biophysical modelling techniques and compared with conventional echocardiographic measurements to evaluate their diagnostic and prognostic performance. Subsequent research results will not be used to guide or modify clinical decisions, treatment, or other aspects of patient care. No study-specific therapeutic intervention is administered.

Sponsors

University of Auckland
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults (at least 18 years of age) able to provide informed consent who are scheduled for, or have recently undergone, a routine clinically indicated echocardiogram.

Exclusion criteria

Unable to provide informed consent.

Outcome results

None listed

Source: ANZCTR · Data processed: Sep 15, 2026